ArticleEMBO molecular medicine2021

Targeted attenuation of elevated histone marks at SNCA alleviates α-synuclein in Parkinson's disease.

Subhrangshu Guhathakurta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.